Ginkgo bioworks SD2 program. The purpose of this action is to award phase i. Ginkgo bioworks shall act as a TA3 SD2 performer, developing software interfaces to transition generated synthetic…
Ended Definitive Contract Awarded Last action
- Contract number
- HR001117C0092
- Awardee
-
Ginkgo Bioworks, Inc. UEI ZRHJUJQSBRA4
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $10,446,304
Award facts
- Opportunity
-
- HR001117S0003 Solicitation number
- High Throughput Biological Experimentation Award Notice · Posted Sep 15, 2017
- Contract value 100% obligated
- $10,446,304.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 23 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Definitize Change Order | $259,911 | |
| Funding Only Action | $419,407 | |
| Exercise an Option | $139,331 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,079,695 | |
| Exercise an Option | $800,000 | |
| Funding Only Action | $1,075,197 | |
| Funding Only Action | $0 | |
| Exercise an Option | $2,000,000 | |
| Funding Only Action | $1,922,368 | |
| Funding Only Action | $501,029 | |
| Other Administrative Action | $0 | |
| Original award | $2,249,366 |
Show all 13
About this award
This federal contract award from the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, has a total ceiling value of $10,446,304.00. The purpose of this Cost Plus Fixed Fee contract is to have Ginkgo Bioworks serve as a TA3 SD2 performer, developing software interfaces to transition generated synthetic biological test results to other software systems as part of the GINKGO BIOWORKS SD2 PROGRAM. This contract is not set aside for any specific business categories. Ginkgo Bioworks has a proven track record of delivering complex scientific services to government entities, including projects across diverse domains such as genomic testing and surveillance, microbiome modulation, and advanced biotechnology solutions for defense and public health challenges. The company has secured numerous federal contract awards and grants, demonstrating its technological capabilities and adaptive approach to complex biotechnological requirements.
Description
Ginkgo bioworks SD2 program. The purpose of this action is to award phase i. Ginkgo bioworks shall act as a TA3 SD2 performer, developing software interfaces to transition generated synthetic biological test results to other software systems.
Quick answers
Who was awarded contract HR001117C0092?
HR001117C0092 was awarded to Ginkgo Bioworks, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on September 15, 2017.
How much is contract HR001117C0092 worth?
The government has obligated $10,446,304 on HR001117C0092.
Was contract HR001117C0092 competed?
The extent of competition for HR001117C0092 was full and open competition. The government received 23 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award